THE DEAL, AT A GLANCE
From the announcementDeepCure
01Who is involvedBacked by VariousFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedDeepCure raised $22M Series AFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersDeepCure’s Series A supports AI-designed drug programs in inflammation and neurodegeneration using deep reinforcement learning.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
DeepCure · Financing Record
Explore source-linked visual explanations for DeepCure. Unsupported claims are withheld while source review continues.
Record 1649 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →